HEADER IMMUNE SYSTEM 22-OCT-25 9YUC TITLE 14-3-3 HETERODIMER BOUND TO PHOSPHORYLATED PYRIN LINKERS COMPND MOL_ID: 1; COMPND 2 MOLECULE: 14-3-3 PROTEIN EPSILON; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 14-3-3E; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: 14-3-3 PROTEIN THETA; COMPND 8 CHAIN: B; COMPND 9 SYNONYM: 14-3-3 PROTEIN T-CELL,14-3-3 PROTEIN TAU,PROTEIN HS1; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: PHOSPHORYLATED PYRIN LINKER 1; COMPND 13 CHAIN: C; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 4; COMPND 16 MOLECULE: PYRIN; COMPND 17 CHAIN: D; COMPND 18 SYNONYM: MARENOSTRIN; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: YWHAE; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: YWHAQ; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_TAXID: 9606; SOURCE 18 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 20 MOL_ID: 4; SOURCE 21 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 22 ORGANISM_COMMON: HUMAN; SOURCE 23 ORGANISM_TAXID: 9606; SOURCE 24 GENE: MEFV, MEF, TRIM20; SOURCE 25 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 26 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS COMPLEX, IMMUNE SYSTEM EXPDTA ELECTRON MICROSCOPY AUTHOR L.LIU,H.WU REVDAT 1 04-NOV-26 9YUC 0 JRNL AUTH L.LIU,H.WU JRNL TITL STRUCTURE OF AN IMMUNE REGULATORY COMPLEX JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 4.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.070 REMARK 3 NUMBER OF PARTICLES : 37559 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9YUC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-OCT-25. REMARK 100 THE DEPOSITION ID IS D_1000301354. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : 14-3-3 HETERODIMER BOUND TO REMARK 245 PHOSPHORYLATED PYRIN LINKERS IN REMARK 245 THE PYRIN INHIBITED COMPLEX REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET B 121 CA - CB - CG ANGL. DEV. = 10.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 108 -119.28 58.41 REMARK 500 ALA B 201 -1.92 67.94 REMARK 500 SEP C 5 -164.62 -75.34 REMARK 500 SEP D 5 -160.98 -107.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-73503 RELATED DB: EMDB REMARK 900 IMMUNE REGULATORY COMPLEX DBREF 9YUC A 1 233 UNP P62258 1433E_HUMAN 1 233 DBREF 9YUC B 1 230 UNP P27348 1433T_HUMAN 1 230 DBREF 9YUC C 1 9 PDB 9YUC 9YUC 1 9 DBREF 9YUC D 1 11 UNP O15553 MEFV_HUMAN 238 248 SEQRES 1 A 233 MET ASP ASP ARG GLU ASP LEU VAL TYR GLN ALA LYS LEU SEQRES 2 A 233 ALA GLU GLN ALA GLU ARG TYR ASP GLU MET VAL GLU SER SEQRES 3 A 233 MET LYS LYS VAL ALA GLY MET ASP VAL GLU LEU THR VAL SEQRES 4 A 233 GLU GLU ARG ASN LEU LEU SER VAL ALA TYR LYS ASN VAL SEQRES 5 A 233 ILE GLY ALA ARG ARG ALA SER TRP ARG ILE ILE SER SER SEQRES 6 A 233 ILE GLU GLN LYS GLU GLU ASN LYS GLY GLY GLU ASP LYS SEQRES 7 A 233 LEU LYS MET ILE ARG GLU TYR ARG GLN MET VAL GLU THR SEQRES 8 A 233 GLU LEU LYS LEU ILE CYS CYS ASP ILE LEU ASP VAL LEU SEQRES 9 A 233 ASP LYS HIS LEU ILE PRO ALA ALA ASN THR GLY GLU SER SEQRES 10 A 233 LYS VAL PHE TYR TYR LYS MET LYS GLY ASP TYR HIS ARG SEQRES 11 A 233 TYR LEU ALA GLU PHE ALA THR GLY ASN ASP ARG LYS GLU SEQRES 12 A 233 ALA ALA GLU ASN SER LEU VAL ALA TYR LYS ALA ALA SER SEQRES 13 A 233 ASP ILE ALA MET THR GLU LEU PRO PRO THR HIS PRO ILE SEQRES 14 A 233 ARG LEU GLY LEU ALA LEU ASN PHE SER VAL PHE TYR TYR SEQRES 15 A 233 GLU ILE LEU ASN SER PRO ASP ARG ALA CYS ARG LEU ALA SEQRES 16 A 233 LYS ALA ALA PHE ASP ASP ALA ILE ALA GLU LEU ASP THR SEQRES 17 A 233 LEU SER GLU GLU SER TYR LYS ASP SER THR LEU ILE MET SEQRES 18 A 233 GLN LEU LEU ARG ASP ASN LEU THR LEU TRP THR SER SEQRES 1 B 230 MET GLU LYS THR GLU LEU ILE GLN LYS ALA LYS LEU ALA SEQRES 2 B 230 GLU GLN ALA GLU ARG TYR ASP ASP MET ALA THR CYS MET SEQRES 3 B 230 LYS ALA VAL THR GLU GLN GLY ALA GLU LEU SER ASN GLU SEQRES 4 B 230 GLU ARG ASN LEU LEU SER VAL ALA TYR LYS ASN VAL VAL SEQRES 5 B 230 GLY GLY ARG ARG SER ALA TRP ARG VAL ILE SER SER ILE SEQRES 6 B 230 GLU GLN LYS THR ASP THR SER ASP LYS LYS LEU GLN LEU SEQRES 7 B 230 ILE LYS ASP TYR ARG GLU LYS VAL GLU SER GLU LEU ARG SEQRES 8 B 230 SER ILE CYS THR THR VAL LEU GLU LEU LEU ASP LYS TYR SEQRES 9 B 230 LEU ILE ALA ASN ALA THR ASN PRO GLU SER LYS VAL PHE SEQRES 10 B 230 TYR LEU LYS MET LYS GLY ASP TYR PHE ARG TYR LEU ALA SEQRES 11 B 230 GLU VAL ALA CYS GLY ASP ASP ARG LYS GLN THR ILE ASP SEQRES 12 B 230 ASN SER GLN GLY ALA TYR GLN GLU ALA PHE ASP ILE SER SEQRES 13 B 230 LYS LYS GLU MET GLN PRO THR HIS PRO ILE ARG LEU GLY SEQRES 14 B 230 LEU ALA LEU ASN PHE SER VAL PHE TYR TYR GLU ILE LEU SEQRES 15 B 230 ASN ASN PRO GLU LEU ALA CYS THR LEU ALA LYS THR ALA SEQRES 16 B 230 PHE ASP GLU ALA ILE ALA GLU LEU ASP THR LEU ASN GLU SEQRES 17 B 230 ASP SER TYR LYS ASP SER THR LEU ILE MET GLN LEU LEU SEQRES 18 B 230 ARG ASP ASN LEU THR LEU TRP THR SER SEQRES 1 C 9 ARG ARG ASN ALA SEP SER ALA GLY ARG SEQRES 1 D 11 MET ARG PRO ARG SEP LEU GLU VAL THR ILE SER MODRES 9YUC SEP D 5 SER MODIFIED RESIDUE HET SEP C 5 10 HET SEP D 5 10 HETNAM SEP PHOSPHOSERINE HETSYN SEP PHOSPHONOSERINE FORMUL 3 SEP 2(C3 H8 N O6 P) HELIX 1 AA1 ARG A 4 ALA A 17 1 14 HELIX 2 AA2 ARG A 19 GLY A 32 1 14 HELIX 3 AA3 THR A 38 GLU A 71 1 34 HELIX 4 AA4 GLY A 75 HIS A 107 1 33 HELIX 5 AA5 HIS A 107 ALA A 112 1 6 HELIX 6 AA6 THR A 114 ALA A 136 1 23 HELIX 7 AA7 GLY A 138 LEU A 163 1 26 HELIX 8 AA8 HIS A 167 ILE A 184 1 18 HELIX 9 AA9 SER A 187 ALA A 204 1 18 HELIX 10 AB1 GLU A 205 LEU A 209 5 5 HELIX 11 AB2 SER A 210 THR A 232 1 23 HELIX 12 AB3 LYS B 3 ALA B 16 1 14 HELIX 13 AB4 ARG B 18 GLY B 33 1 16 HELIX 14 AB5 SER B 37 THR B 69 1 33 HELIX 15 AB6 LYS B 74 TYR B 104 1 31 HELIX 16 AB7 ASN B 111 GLU B 131 1 21 HELIX 17 AB8 GLY B 135 MET B 160 1 26 HELIX 18 AB9 HIS B 164 GLU B 180 1 17 HELIX 19 AC1 ASN B 184 ILE B 200 1 17 HELIX 20 AC2 GLU B 202 LEU B 206 5 5 HELIX 21 AC3 SER B 210 SER B 230 1 21 LINK C ALA C 4 N SEP C 5 1555 1555 1.33 LINK C SEP C 5 N SER C 6 1555 1555 1.33 LINK C ARG D 4 N SEP D 5 1555 1555 1.33 LINK C SEP D 5 N LEU D 6 1555 1555 1.33 CISPEP 1 LYS A 215 ASP A 216 0 9.25 CISPEP 2 GLU B 2 LYS B 3 0 0.00 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 3749 3752 CONECT 3752 3749 3753 CONECT 3753 3752 3754 3756 CONECT 3754 3753 3755 CONECT 3755 3754 3758 CONECT 3756 3753 3757 3762 CONECT 3757 3756 CONECT 3758 3755 3759 3760 3761 CONECT 3759 3758 CONECT 3760 3758 CONECT 3761 3758 CONECT 3762 3756 CONECT 3818 3827 CONECT 3827 3818 3828 CONECT 3828 3827 3829 3831 CONECT 3829 3828 3830 CONECT 3830 3829 3833 CONECT 3831 3828 3832 3837 CONECT 3832 3831 CONECT 3833 3830 3834 3835 3836 CONECT 3834 3833 CONECT 3835 3833 CONECT 3836 3833 CONECT 3837 3831 MASTER 141 0 2 21 0 0 0 6 3879 4 24 38 END